中南米の2030年までの乳がん治療薬市場予測 - 地域分析 - 薬物療法別 [標的薬物療法 (アベマシクリブ、Ado-トラスツズマブ エムタンシン、パルボシクリブ、トラスツズマブ、その他の標的薬物療法)、ホルモン薬物療法 (選択的エストロゲン受容体調節物質、 「アロマターゼ阻害剤、選択的エストロゲン受容体ダウンレギュレーター）、化学療法、免疫療法/生物学的療法」、乳がんの種類（ホルモン受容体、HER2+、トリプルネガティブ乳がん）、流通チャネル（病院の薬局、ドラッグストア、小売薬局、オンライン薬局）
中南米の乳がん治療市場、個別化医療燃料の使用が増加
個別化医療には治療計画の調整が含まれます他の要因の中でも特に、遺伝子構造に基づいて個々の患者に適用されます。このアプローチは、各患者のがんの固有の特性を考慮するため、高度に的を絞った効果的な治療を可能にします。ゲノミクスと分子診断の進歩により、個別化医療が乳がん治療における実行可能な選択肢になりました。医療提供者は、患者の腫瘍を分子レベルで分析することで、がんの増殖を促進する特定の遺伝子変異やバイオマーカーを特定できます。この情報は、特定の患者にとって最も効果的である可能性が高い、標的療法や免疫療法などの最も適切な治療オプションを選択するために使用できます。乳がん治療における個別化医療の使用には、患者の転帰を大幅に改善する可能性があります。たとえば、2022 年 2 月、NIH の研究者らは、患者の腫瘍と戦う免疫細胞を使用して転移性乳がん患者を治療する免疫療法の実験的な形態である、個別化乳がん治療アプローチを開発し、個別化医療を前進させました。
中南米の乳がん治療薬市場の概要
中南米の乳がん治療薬市場は、ブラジル、アルゼンチン、およびその他の中南米に分割されています。ブラジルはこの地域で大きなシェアを占めると予想されている。また、最も高い成長率で成長すると予測されています。乳がんの有病率の増加、人口の高齢化、一人当たりの医療支出の増加は、乳がん治療市場を急速に推進すると予想される要因の一つです。
ブラジルにおける乳がんの罹患率の増加により、乳がん治療薬の需要が高まっています。 Nature Publications によると、乳がんはブラジルの女性で最も罹患している悪性腫瘍です。ブラジル国立がん研究所 (INCA) によると、ブラジルでは毎年約 66,200 人の女性の乳がんの新規症例が確認されており、年齢標準化罹患率に換算すると女性 100,000 人あたり 43.74 人になります。
ブラジルにおける医療インフラの改善と高度な医療技術へのアクセスも市場を推進します。政府は医療施設の拡充と、乳がんの検査や治療を含む医療サービスへのアクセスの改善に投資してきました。これにより、乳がん症例の早期発見が可能となり、治療に対する需要が増加しました。したがって、乳がんの有病率の増加、医療インフラの改善、乳がんへの意識の高まりが、ブラジルの乳がん治療市場を推進する重要な要因となっています。
中南米の乳がん治療薬市場の収益と2030年までの予測（百万米ドル）
中南米の乳がん治療薬市場のセグメンテーション
中南米乳がん治療薬市場は、薬物療法、乳がんの種類、流通チャネルに基づいて分割されています。
薬物療法に基づいて、中南米の乳がん治療市場は、標的薬物療法、ホルモン薬物療法、化学療法、免疫療法/生物学的療法に分類されます。分子標的薬治療セグメントは、2022年にはより大きなシェアを保持しました。分子標的薬治療セグメントは、2022年にはより大きなシェアを保持しました。分子標的薬治療セグメントは、アベマシクリブ、アドトラスツズマブ エムタンシン、パルボシクリブ、トラスツズマブ、およびその他の標的薬物療法にさらにサブセグメント化されています。さらに、ホルモン薬物療法セグメントは、選択的エストロゲン受容体モジュレーター、アロマターゼ阻害剤、選択的エストロゲン受容体ダウンレギュレーターに分類されます。
乳がんの種類に関して、中南米の乳がん治療市場はホルモン受容体、HER2+、トリプルネガティブ乳がんに分類されます。 2022 年には、ホルモン受容体セグメントがより大きなシェアを占めました。
中南米の乳がん治療薬市場は、流通チャネルごとに、病院薬局、ドラッグストアおよび小売薬局、オンライン薬局に分類されます。 2022 年には、病院薬局セグメントがより大きなシェアを占めました。
中南米の乳がん治療薬市場は、国別にブラジル、アルゼンチン、その他の中南米に分類されます。ブラジルは、2022 年に中南米の乳がん治療薬市場を独占しました。
イーライリリー社、エーザイ株式会社、ノバルティス AG、アストラゼネカ Plc、ファイザー社、ギリアド サイエンシズ社、メルク社、テバ ファーマシューティカル インダストリーズLtd および Amgen Inc は、中南米の乳がん治療市場で事業を展開する大手企業の一部です。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Breast Cancer Therapeutics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Growing Burden of Breast Cancer
4.1.2 Launch of Several Diagnostics and Screening Programs
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis and Treatment
4.3 Key Market Opportunities
4.3.1 Increased Support from Government and Private Organizations
4.4 Key Future Trends
4.4.1 Increasing Use of Personalized Medicine
4.5 Impact Analysis:
5. Breast Cancer Therapeutics Market - South & Central America Market Analysis
5.1 South & Central America Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy
6.1 Overview
6.2 South & Central America Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
6.3 Targeted Drug Therapy
6.3.1 Overview
6.3.2 Targeted Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 South & Central America Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)
6.4 Hormonal Drug Therapy
6.4.1 Overview
6.4.2 Hormonal Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 South & Central America Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)
6.5 Chemotherapy
6.5.1 Overview
6.5.2 Chemotherapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Immunotherapy/ Biological Therapy
6.6.1 Overview
6.6.2 Immunotherapy/ Biological Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type
7.1 Overview
7.2 South & Central America Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
7.3 Hormone Receptor
7.3.1 Overview
7.3.2 Hormone Receptor: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 HER2+ (human epidermal growth factor receptor 2)
7.4.1 Overview
7.4.2 HER2+: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Triple-Negative Breast Cancer
7.5.1 Overview
7.5.2 Triple-Negative Breast Cancer: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 South & Central America Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Drug Store and Retail Pharmacies
8.4.1 Overview
8.4.2 Drug Store and Retail Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Breast Cancer Therapeutics Market -Country Analysis
9.1 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.2 South & Central America Breast Cancer Therapeutics Market, Breakdown, by Country -Revenue (2022) (US$ Million)
9.1.3 South & Central America Breast Cancer Therapeutics Market, By Countries, 2022 and 2030 (%)
9.1.3.1 Brazil
9.1.3.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.2 Argentina
9.1.3.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.3 Rest of South & Central America
9.1.3.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Breast Cancer Therapeutics Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in Breast Cancer Therapeutics Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eli Lilly and Co
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eisai Co Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AstraZeneca Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Gilead Sciences Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck & Co Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Amgen Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. South & Central America Breast Cancer Therapeutics Market Segmentation
Table 2. South & Central America Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Brazil Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
Table 20. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
Table 21. Glossary of Terms, Breast Cancer Therapeutics Market
List of Figures
Figure 1. South & Central America Breast Cancer Therapeutics Market Segmentation, By Country
Figure 2. South & Central America Breast Cancer Therapeutics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
Figure 6. Targeted Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Hormonal Drug Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Chemotherapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunotherapy/ Biological Therapy: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. South & Central America Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
Figure 11. Hormone Receptor: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. HER2+: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Triple-Negative Breast Cancer: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
Figure 15. Hospital Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Drug Store and Retail Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Online Pharmacies: South & Central America Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 19. South & Central America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Growth Strategies in Breast Cancer Therapeutics Market
1. Eli Lilly and Co
2. Eisai Co Ltd
3. Novartis AG
4. AstraZeneca Plc
5. Pfizer Inc
6. Gilead Sciences Inc
7. Merck & Co Inc
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America breast cancer therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South & Central America breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution